Trial Profile
Effect of food on the pharmacokinetic profile of saquinavir at steady state in HIV-infected patients treated with saquinavir/ritonavir 1000/100 mg b.i.d.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Saquinavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 03 Aug 2019 Status changed from recruiting to completed.
- 17 May 2011 New trial record